Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1930 1
1934 6
1935 2
1936 6
1946 1
1950 1
1951 1
1953 1
1954 1
1955 1
1956 1
1957 1
1958 2
1959 6
1961 1
1962 1
1963 1
1964 5
1965 9
1966 3
1967 2
1968 1
1969 3
1970 4
1972 1
1973 5
1974 2
1975 2
1976 7
1977 5
1978 9
1979 6
1980 3
1981 7
1982 11
1983 14
1984 19
1985 29
1986 26
1987 35
1988 38
1989 28
1990 36
1991 31
1992 49
1993 37
1994 43
1995 28
1996 45
1997 50
1998 49
1999 56
2000 69
2001 85
2002 76
2003 120
2004 130
2005 153
2006 203
2007 237
2008 293
2009 314
2010 440
2011 445
2012 569
2013 669
2014 713
2015 827
2016 838
2017 964
2018 1089
2019 1247
2020 1486
2021 1765
2022 1862
2023 1886
2024 2044
2025 2287
2026 786

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19,959 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence-powered nanomedicine.
Luo G, Jiang X, Hu C, Li L, Yan L, Xiao G, Duo Y, Zhang X. Luo G, et al. Among authors: hu c. Chem Soc Rev. 2026 Feb 23;55(4):2070-2119. doi: 10.1039/d5cs01406a. Chem Soc Rev. 2026. PMID: 41636234 Review.
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.
Duan JC, Zhong J, Sun BY, Zhao WH, Wu L, Fei KL, Chu Q, Guo QS, Song QB, Yu Y, Zhu DX, Liu XY, Zhao J, Zhan ZX, Li S, Nie L, Lin J, Peng XD, Zhong DS, Zhou J, Li LH, Chen YF, Hu C, Mok T, Wang ZJ, Wang J. Duan JC, et al. Among authors: hu c. CA Cancer J Clin. 2026 Mar-Apr;76(2):e70071. doi: 10.3322/caac.70071. CA Cancer J Clin. 2026. PMID: 41818162 Free PMC article. Clinical Trial.
Reciprocal regulation of fibroblast-macrophage equilibrium governs skin integrity.
Vollmers AC, Wu SZ, Altieri A, McCartney EE, Bender H, Davidson CD, Lee WP, Zhang J, Hu C, Jeet S, Hall B, Irizarry-Caro RA, Guarnieri A, Santosa EK, Preston J, Uttarwar S, Vander Heiden JA, Chung Y, Ortiz W, Long M, Asuncion R, Yang YA, Jiang JX, Modrusan Z, Chintalacharuvu S, Moussion C, Krishnamurty AT, Fu W, Müller S, Buechler MB, Turley SJ. Vollmers AC, et al. Among authors: hu c. Nat Immunol. 2026 Apr;27(4):700-714. doi: 10.1038/s41590-026-02434-5. Epub 2026 Feb 27. Nat Immunol. 2026. PMID: 41760904 Free PMC article.
[Research progress in microneedle-mediated vaccination].
Wang Z, Li X, Zhang Y, Shi R, Hu C, Xin W, Kang L, Wang J, Wang J, Yang H, Gao S. Wang Z, et al. Among authors: hu c. Sheng Wu Gong Cheng Xue Bao. 2025 Nov 13;42(2):678-694. doi: 10.13345/j.cjb.250552. Sheng Wu Gong Cheng Xue Bao. 2025. PMID: 41755600 Free article. Review. Chinese.
Genetic risk loci for Parkinson's disease and dementia in a large-scale population-based Taiwanese cohort (TPMI).
Lin CH, Chang CC, Chen HH, Lin WJ, Hsu CL, Lin RJ, Guo YJ, Fang TC, Lin SZ, Huang CY, Wang SJ, Hang JF, Hsieh SW, Chou MC, Yeh TH, Hu CJ, Yang FC, Chang HA, Lee TH, Tsai MH, Kuo MC, Liou JM, Wu MS, Park KW, Chung SJ, Tan EK, Shen-Jang Fann C. Lin CH, et al. Among authors: hu cj. Lancet Reg Health West Pac. 2026 Mar 4;68:101825. doi: 10.1016/j.lanwpc.2026.101825. eCollection 2026 Mar. Lancet Reg Health West Pac. 2026. PMID: 41810385 Free PMC article.
Digital-Twin Enabled "Living Fresco".
Wu S, Chen Q, Hu C, An Y, Han F. Wu S, et al. Among authors: hu c. ACS Omega. 2026 Jan 23;11(5):8011-8023. doi: 10.1021/acsomega.5c10292. eCollection 2026 Feb 10. ACS Omega. 2026. PMID: 41696343 Free PMC article.
Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial.
Huang Y, Sun D, Zhou H, Zhou T, Qu S, Li J, Hu C, Xu M, Li W, Shen L, Wu H, Lang J, Hu G, Luo Z, Fu Z, Qu S, Feng W, Chen X, Lin S, Xie B, Li X, Sun Y, Lin Z, Lin Q, Lei F, Long J, Hong J, Huang X, Zeng L, Wang P, He X, Zhao S, Chen G, Zhang Y, Zhao Y, Fang W, Huang C, Li X, Hong S, Zhang L, Yang Y. Huang Y, et al. Among authors: hu c. JAMA Oncol. 2026 Mar 1;12(3):295-302. doi: 10.1001/jamaoncol.2025.6245. JAMA Oncol. 2026. PMID: 41609753 Free PMC article. Clinical Trial.
19,959 results
You have reached the last available page of results. Please see the User Guide for more information.